Checkmate Pharmaceuticals Inc Shares Close the Week 20.5% Lower - Weekly Wrap
The company saw its shares close the week 20.5% lower than last week, with trading volume higher than its 30 day average.
Sep 18, 2021 by Kwhen Finance Editors
Checkmate Pharmaceuticals Inc (CMPI) shares closed this week 20.5% lower than it did at the end of last week. The stock is currently down 68.3% year-to-date, down 59.8% over the past 12 months, and down 67.0% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.4%.
Trading Activity
- Shares traded as high as $5.34 and as low as $4.45 this week.
- Shares closed 78.9% below its 52-week high and 14.9% above its 52-week low.
- Trading volume this week was 79.0% higher than the 10-day average and 118.8% higher than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.8.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
- The stock closed at 2.8% higher than its 5-day moving average, 9.7% lower than its 20-day moving average, and 15.6% lower than its 90-day moving average.
Market Comparative Performance
- The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Checkmate Pharmaceuticals Inc | 5.4 | -68.3 | -59.8 | -79.4 | 12.0 |
| Dow Jones Industrial Average | -0.7 | 15.1 | 26.1 | -2.6 | 34.6 |
| S&P 500 Index | -1.3 | 20.4 | 33.9 | -2.0 | 40.6 |
| Technology Industry | 4.6 | -53.0 | -71.2 | -74.7 | 4.6 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 167.4%
- The company's stock price performance over the past 12 months lags the peer average by 434.8%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Checkmate Pharmaceuticals Inc | CMPI | 0 | -68.3 | -59.8 | -79.4 | 12.0 |
| Peer Avg | N/A | 0 | -25.6 | -11.2 | -28.3 | 26.9 |
| ORIC Pharmaceuticals Inc | ORIC | 0 | -27.4 | 12.2 | -36.1 | 66.4 |
| Otonomy Inc | OTIC | 0 | -74.8 | -57.0 | -76.9 | 41.2 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: